KCNA5 and gastric cancer: The up regulation of Kv1.5 increased the sensitivity of human gastric cancer (SGC7901) cells to chemotherapeutic drugs [36], and Kv1.1 specific blocker reduced gefitinib-resistant H460 cell viability [37].